title: Acquired reactive perforating collagenosis associated with systemic lupus erythematosus.
authors.affiliation: Department of Dermatology, Fukushima Medical University, Fukushima, Japan.
authors.forename: Takenobu
authors.initials: T
authors.lastname: Ohashi
authors.affiliation: Department of Dermatology, Fukushima Medical University, Fukushima, Japan.
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Yamamoto
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001415:Back; D003095:Collagen Diseases / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D004817:Epidermis / Q000378:metabolism / Q000473:pathology; D000068800:Etanercept / Q000008:administration & dosage / Q000627:therapeutic use; D005145:Face; D005260:Female; D024022:Fibrillar Collagens / Q000378:metabolism*; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D012871:Skin Diseases / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology
chemical_list: D018501:Antirheumatic Agents; D024022:Fibrillar Collagens; D005938:Glucocorticoids; D011239:Prednisolone; D000068800:Etanercept; D008727:Methotrexate